Nicholas K. Akers

2.6k total citations · 1 hit paper
11 papers, 744 citations indexed

About

Nicholas K. Akers is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Nicholas K. Akers has authored 11 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Nicholas K. Akers's work include Cancer Immunotherapy and Biomarkers (3 papers), vaccines and immunoinformatics approaches (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Nicholas K. Akers is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), vaccines and immunoinformatics approaches (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Nicholas K. Akers collaborates with scholars based in United States, Netherlands and Italy. Nicholas K. Akers's co-authors include Bojan Losic, Augusto Villanueva, Daniela Sia, Juan Putra, Samuel Waxman, Josep M. Llovet, Genís Campreciós, M. Schwartz, Scott L. Friedman and Manuel Castro de Moura and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and Gastroenterology.

In The Last Decade

Nicholas K. Akers

11 papers receiving 742 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

2017 632 citations Daniela Sia, Yang Jiao et al. Gastroenterology profile →

Peers

Countries citing papers authored by Nicholas K. Akers

Since Specialization

Citations

This map shows the geographic impact of Nicholas K. Akers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas K. Akers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas K. Akers more than expected).

Fields of papers citing papers by Nicholas K. Akers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas K. Akers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas K. Akers. The network helps show where Nicholas K. Akers may publish in the future.

Co-authorship network of co-authors of Nicholas K. Akers

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas K. Akers. A scholar is included among the top collaborators of Nicholas K. Akers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas K. Akers. Nicholas K. Akers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial 2025 ·EBioMedicine ·Nina Hertoghs, (unknown), (unknown), Jerald Sadoff, Barbara L. Banbury, Nicholas K. Akers, Bryan Howie, Harlan Robins, (unknown), Jeroen Tolboom, Veronica V. Rezelj, Jenny Hendriks, Hanneke Schuitemaker, Daniel J Stieh, Mathieu Le Gars	1
2	Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors 2020 ·Scientific Reports ·(unknown), Edgar Gonzalez‐Kozlova, Nicholas K. Akers, Augusto Villanueva, Bojan Losic	6
3	STAR Chimeric Post for rapid detection of circular RNA and fusion transcripts 2018 ·Bioinformatics ·Nicholas K. Akers, Eric E. Schadt, Bojan Losic	18
4	Quantitative Comparison of Active and Passive Stormwater Infrastructure: Case Study in Beckley, West Virginia 2018 ·Proceedings of the Water Environment Federation ·Dayton Marchese, Jeremiah Johnson, Nicholas K. Akers, Matt L. Huffman, (unknown)	4
5	Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features breakdown → 2017 ·Gastroenterology ·Daniela Sia, Yang Jiao, Iris Martinez-Quetglas, Olga Kuchuk, Carlos Villacorta-Martín, Manuel Castro de Moura, Juan Putra, Genís Campreciós, Laia Bassaganyas, Nicholas K. Akers, Bojan Losic, Samuel Waxman, Swan N. Thung, Vincenzo Mazzaferro, Manel Esteller, Scott L. Friedman, M. Schwartz, Augusto Villanueva, Josep M. Llovet	632
6	Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N‐6 adenine‐specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population 2017 ·Environmental and Molecular Mutagenesis ·Rosemarie de la Rosa, Craig Steinmaus, Nicholas K. Akers, Lucía Conde, Catterina Ferreccio, David A. Kalman, (unknown), Christine F. Skibola, Allan H. Smith, Luoping Zhang, Martyn T. Smith	32
7	DNA damage response (DDR) gene mutations (mut), mut load, and sensitivity to chemotherapy plus immune checkpoint blockade in urothelial cancer (UC). 2017 ·Journal of Clinical Oncology ·Matt D. Galsky, Andrew Uzilov, Russell B. McBride, Huan Wang, Vaibhav G. Patel, John P. Sfakianos, Li Wang, Nicholas K. Akers, Gopa Iyer, David B. Solit, Takuro Saito, Mireia Castillo-Martín, Noah M. Hahn, Sumanta K. Pal, Mark T. Fleming, Ralph J. Hauke, Bojan Losic, Sacha Gnjatic, Rong Chen, Nina Bhardwaj	8
8	Follicular lymphoma-protective HLA class II variants correlate with increased HLA-DQB1 protein expression 2013 ·Genes and Immunity ·Fenna C.M. Sillé, Lucía Conde, (unknown), Nicholas K. Akers, (unknown), Joanna H. Maltbaek, Jacques Riby, Martyn T. Smith, Christine F. Skibola	5
9	Multi‐locus HLA class I and II allele and haplotype associations with follicular lymphoma 2012 ·Tissue Antigens ·Christine F. Skibola, Nicholas K. Akers, Lucía Conde, Martha Ladner, (unknown), Flossie Cohen, (unknown), (unknown), Damian Goodridge, Elizabeth Trachtenberg, Martyn T. Smith, Paige M. Bracci	25
10	Multiplexed, ligation‐dependent probe amplification for rapid and inexpensive HLA‐DQB1 allelotyping 2011 ·Tissue Antigens ·Nicholas K. Akers, (unknown), Martyn T. Smith, Paige M. Bracci, Christine F. Skibola	2
11	Association ofHLA-DQB1alleles with risk of follicular lymphoma 2010 ·Leukemia & lymphoma ·Nicholas K. Akers, John Curry, Lucía Conde, Paige M. Bracci, Martyn T. Smith, Christine F. Skibola	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact